marijuana stock news

VitaCig(R) Appoints Hollywood Actor and Producer Al Santos as Chief Executive Officer, Prepares for Public Listing

BEVERLY HILLS, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) — VitaCig(R), Inc. (OTCQB:Pending Stock Symbol) (“VitaCig”), a technology company that owns, manufactures, and distributes the VitaCig(R) products, is pleased to announce the official appointment of Alfred Santos as Chief Executive Officer of VitaCig Inc. in preparation for its public listing.

Al was born and raised in New York City. He was discovered in 1991 at the age of 15 by the world famous Ford Modeling agency which signed him to be the face of Versace. From 1991-2001 Santos was one of the most successful male models in the world having been featured on the covers of magazines: Seventeen, YM, Teen Vogue, American Fitness, and Elle. He was also featured in campaigns for Versace, Armani, Dolce & Gabbana, Levi’s, Lee, American Eagle, and Wrangler. In 2001, Al was named “Man of the Year” by Cosmopolitan magazine. The title and Al became a sensation leading to repeated mentions by Howard Stern and Regis Philbin on their daily shows and making Al one of the most visible male faces in the US.

In 2002, Al made the decision to leave the modeling business and go back to school. He studied Sciences at Hunter College and began training with acting coach Penny Templeton. Following his training, he was cast as the male lead to Darren Star’s critically acclaimed show: “Grosse Pointe” which ran for two seasons on the WB network. In 2003, Al was cast as a lead for MGM/Francis Ford Coppola’s Jeepers Creepers II the horror franchise which debuted at #1 at the box office for several weeks.

Following the success of Jeepers Creepers, Al changed his focus to production of films as well as investing. He founded a production company: StrongHold Productions. He also began leveraging his decade long relationships in film, media, and Hollywood to launch and invest in several technology businesses.

Santos initially discovered VitaCig as a customer in the spring of 2014. After falling in love with the product he reached out to VitaCig Inc. and developed a close relationship with management. Santos was instrumental in closing several key transactions for mCig and VitaCig as well as critical celebrity introductions that helped the product achieve the adoption it has in such a short amount of time.

Over the past two months, VitaCig management extended an offer to Mr. Santos to lead VitaCig, recognizing the potential he brings to the table. During this period, Al and his team in Beverly Hills prepared a robust strategic marketing plan for VitaCig to be rolled out over the next 24 months.

“I am both humbled and honored to be joining VitaCig, Inc. as the newly appointed Chief Executive Officer. I came across this incredible product by chance, when a friend shared a VitaCig refresh with me several days after it was launched. As a long time health and technology advocate, I knew the first moment I inhaled the VitaCig, that this product had world-changing potential. After several weeks of investigating and using the product, I felt the product needed a stronger face and initiative. To my surprise, the Vita Team not only embraced these initiatives, but provided the tools needed to execute the international plan as described. VitaCig is an opportunity that only comes along once in ones life, not just for myself, but for the people we can have a positive impact upon. I do not see a scenario where VitaCig just fizzles out. It will succeed and become the newest and most innovative Vitamin Delivery System of all time. Furthermore, when you review the pipeline of products we have scheduled to launch over the next 12 months, Vita is a name every household worldwide will soon recognize, and be using”.

“Our ties to mCig, Inc. will remain strong but our paths have officially diverted. While mCig will now focus exclusively on the Cannabis-Marijuana industries, we are focused exclusively on maximizing the potential for VitaCig as a leading consumer brand with significant opportunity for horizontal category expansion. I look forward to updating all shareholders shortly and obtaining our stock symbol for public listing expeditiously. Thank You in advance for your support.” Said Al Santos, newly appointed CEO of VitaCig Inc.

“We are extremely excited to be welcoming Al to VitaCig, Inc. As our newly appointed Chief Executive Officer. We could not be more indebted to Al for several key events he has made possible in our company’s history. The idea behind his appointment was his own, and I fully support his plan which will be rolled out over the coming months. mCig, Inc. stands to benefit greatly from future success at VitaCig, Inc. As the largest shareholder with over 230,000,000 shares representing nearly 47% of the shares outstanding upon listing, we stand to earn significant sums that will allow us to strengthen our balance sheet further and invest in opportunities that can grow shareholder value over time for mCig, Inc. shareholders. In other words, our fates are intertwined.” Said Paul Rosenberg, CEO of mCig, Inc.

About VitaCig, Inc.

VitaCig, Inc. (Stock Symbol: Pending) is a technology company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig(R), a $5 nicotine-free device. Unlike a traditional eCig, the VitaCig(R) delivers a water-vapor of natural flavors, vitamins, terpenes, and phytonutrients.

VitaCig, Inc. is disrupting both the traditional tobacco industry and the emerging personal vaporizer market by appealing to the 1.2 billion adults globally that smoke cigarettes. VitaCig(R) accomplishes this by providing a nicotine and tobacco- free alternative that may assist in harm reduction.

About mCig, Inc.

mCig, Inc. (MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as “eCigs”) by the world’s 1.2 Billion smokers. The company manufactures and retails the mCig(R) — the world’s most affordable vaporizer priced at only $10. Designed in the USA — the mCig(R) provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc. which manufactures and retails home-use vaporizers such as the Vapolution 3.0. mCig, Inc. also owns a 47% stake in VitaCig, Inc. a company that manufactures and retails the VitaCig(R), a $5 nicotine-free eCig that delivers a water-vapor mixed with vitamins and natural flavors. See more at:https://www.mCig.org/, www.Vapolution.com, and www.VitaCig.org.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.

Contact:
Al Santos
CEO
1 (425) 652-5946

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 Lifestyle Delivery Systems Inc. (LDSYF) Announces the Adelanto City Council’s Approval to Include Cannabis Adult Use into the City Regulations

Lifestyle Delivery Systems Inc. Announces the Adelanto City Council’s Approval to Include…

GT Biopharma, Inc. (GTBP) Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial

GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550…

$FNREF Provides Update on California Cannabis Product Offerings

Finore Mining Provides Update on California Cannabis Product Offerings and Name Change…